Literature DB >> 31988058

Severe early-onset ovarian hyperstimulation syndrome with liver dysfunction in an IVF segmentation cycle.

Neeta Singh1, Yogita Dogra2, Monika Saini1, Matheswari Govindarajan1.   

Abstract

Severe early-onset ovarian hyperstimulation syndrome (OHSS) with deranged liver function tests is an entity that cannot be eliminated wholly even after gonadotropin-releasing hormone (GnRH) agonist trigger without any luteal human chorionic gonadotropin (hCG) rescue in a GnRH antagonist protocol with the freeze-all approach. We describe a case of young polycystic ovary syndrome patient with prior history of severe early-onset OHSS in her last in vitro fertilisation cycle in which she received antagonist protocol followed by blastocyst transfer. Given her history, she was planned for agonist trigger and freeze all approach during the present cycle. Despite segmentation of the cycle without any luteal rescue hCG, she developed early-onset severe OHSS with markedly deranged liver function tests for which she underwent ascitic tapping and remained hospitalised for 8 days. Her symptoms improved with conservative management, and she was discharged satisfactorily. She underwent letrozole based frozen-thawed embryo transfer cycle after 4 months. One good quality blastocyst was transferred, and she conceived in the same cycle. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  pregnancy; reproductive medicine

Mesh:

Substances:

Year:  2020        PMID: 31988058      PMCID: PMC7035818          DOI: 10.1136/bcr-2019-233379

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  23 in total

1.  Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles.

Authors:  Tsung-Hsien Lee; Chung-Hsien Liu; Chuin-Chia Huang; Yi-Ling Wu; Yang-Tse Shih; Hong-Nerng Ho; Yu-Shih Yang; Maw-Shang Lee
Journal:  Hum Reprod       Date:  2007-11-13       Impact factor: 6.918

Review 2.  An OHSS-Free Clinic by segmentation of IVF treatment.

Authors:  Paul Devroey; Nikolaos P Polyzos; Christophe Blockeel
Journal:  Hum Reprod       Date:  2011-08-09       Impact factor: 6.918

3.  Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles.

Authors:  A La Marca; E Papaleo; V Grisendi; C Argento; S Giulini; A Volpe
Journal:  BJOG       Date:  2012-07-17       Impact factor: 6.531

4.  Elevated liver function tests in a case of moderate ovarian hyperstimulation syndrome.

Authors:  A N Wakim; S D Fox
Journal:  Hum Reprod       Date:  1996-03       Impact factor: 6.918

5.  Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction.

Authors:  Claudio Alvarez; Luis Martí-Bonmatí; Edurne Novella-Maestre; Roberto Sanz; Raúl Gómez; Manuel Fernández-Sánchez; Carlos Simón; Antonio Pellicer
Journal:  J Clin Endocrinol Metab       Date:  2007-04-24       Impact factor: 5.958

6.  A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome.

Authors:  Lucia Montanelli; Anne Delbaere; Costantino Di Carlo; Carmine Nappi; Guillaume Smits; Gilbert Vassart; Sabine Costagliola
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

7.  Liver abnormality in ovarian hyperstimulation syndrome.

Authors:  N G Ryley; R Forman; D Barlow; K A Fleming; J M Trowell
Journal:  Hum Reprod       Date:  1990-11       Impact factor: 6.918

8.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

Authors: 
Journal:  Fertil Steril       Date:  2004-01       Impact factor: 7.329

9.  Are we choosing the correct FSH starting dose during controlled ovarian stimulation for intrauterine insemination cycles? Potential application of a nomogram based on woman's age and markers of ovarian reserve.

Authors:  Rossana Di Paola; Simone Garzon; Sara Giuliani; Antonio Simone Laganà; Marco Noventa; Francesca Parissone; Carlotta Zorzi; Ricciarda Raffaelli; Fabio Ghezzi; Massimo Franchi; Stefano Zaffagnini
Journal:  Arch Gynecol Obstet       Date:  2018-09-21       Impact factor: 2.344

Review 10.  Ovarian Hyperstimulation Syndrome: A Narrative Review of Its Pathophysiology, Risk Factors, Prevention, Classification, and Management.

Authors:  Bahia Namavar Jahromi; Mohammad Ebrahim Parsanezhad; Zahra Shomali; Pardis Bakhshai; Mahshid Alborzi; Najmeh Moin Vaziri; Zahra Anvar
Journal:  Iran J Med Sci       Date:  2018-05
View more
  1 in total

1.  Severe late-onset ovarian hyperstimulation syndrome presenting with liver dysfunction after in vitro fertilization: A case report.

Authors:  Jennifer J Chae-Kim; Robert Roman; Kristina Hawkins; Larisa Gavrilova-Jordan
Journal:  Case Rep Womens Health       Date:  2021-06-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.